Non-Conforming Material: Return, Replace or Downgrade

A batch fails a test. The commercial conversation starts immediately, and it usually starts in the wrong place: what does the customer want, and what is cheapest. The technical question comes later, if at all, and it is the one that determines whether the resolution holds up in an inspection.

Three routes exist. Two of them leave the material as it is. The third changes what the material is, and that is a different category of act.

The three routes, side by side

	Return	Replacement	Downgrade
Material identity	Unchanged	New batch, same identity	Changed grade
Who bears the loss	Supplier	Supplier	Depends on the new market
Documentation	Return note, credit, disposition record	New certificate, new batch record	New specification, new label, justification
Regulatory exposure	Low, if the material never left control	Low	High, if the new grade is not genuinely applicable

The table's last row is the reason this is not a commercial decision. A return that is documented is a closed event. A downgrade that is not justified is a non-conformance with a new label on it, and the label does not change what happened in the reactor.

Downgrade, and the three conditions

A downgrade is legitimate when the material meets a different specification, that specification corresponds to a real use, and the decision is recorded before the material is offered rather than after a customer objects.

A specification it meets. Not "lower grade" as a phrase, but a document with tests and limits. This is where many downgrades fail, because the alternative grade exists as a price point rather than as a specification. The four-market comparison of non-pharma grades shows how differently the same molecule is specified for feed, technical, cosmetic and research use, and how little of that difference is captured by the word "technical".

A use that permits it. The customer's application has to be outside the scope the failed specification served. Material that missed a microbial limit for pharmaceutical use is not thereby suitable for a feed application, because feed has its own microbiological expectations and they are not uniformly looser.

A record made in advance. The justification, the alternative specification, the customer's confirmation of use, and the batch's full test history travel together. A downgrade documented after the fact looks like what it is.

Return, and the part people forget

A return has a physical leg that is often handled casually. The material comes back, sits in a quarantine area, and is eventually dealt with. What matters for the record is the condition on arrival, because a drum that travelled badly is not the same drum that left.

The return note should carry the quantity, the packaging condition, the seal status, and a decision: rework, retest, or destroy. A return with no disposition decision becomes inventory that nobody owns, and inventory that nobody owns eventually gets used.

Replacement, and the investigation that it does not replace

Replacing quickly is good commercial behaviour and poor quality behaviour if it substitutes for the investigation. The customer's problem is solved by the new batch. The site's problem is not, and the second failure will arrive with the same root cause and a customer who is now suspicious.

The complaint loop is where this is tested: a corrective action without an effectiveness check is a statement of intent. Replacement plus an investigation plus a check that the next three batches behaved is a closed loop. Replacement alone is a favour.

When the material has already moved

If the batch was shipped and used, the question is no longer disposition. It is whether the customer's product is affected, which is the customer's regulatory decision, and the supplier's job is to supply the facts quickly: how many batches, what quantity, what dates, what the deviation was, and what the potential impact is.

Speed matters more than completeness in the first communication, provided the incompleteness is stated. A supplier who says "we have identified three affected batches and are still checking whether a fourth exists" is more useful than one who waits a week for a complete answer. The classification of the deviation decides who has to be told and how quickly, and it should be applied before the material moves rather than after.

The question that reveals a system

Ask a supplier to describe the last three non-conformances and how each was dispositioned. The answer is more informative than an audit checklist, because it shows whether the site distinguishes between the three routes or treats them as one.

A mature answer sounds like this: one lot returned and reworked, one downgraded to a technical grade with the customer's written confirmation of use, one destroyed because neither route applied. An immature answer sounds like this: we replaced them.

We describe each disposition in those terms, and we keep the justification with the batch record rather than in a commercial file. The general expectations for handling non-conforming material are set out in the ICH quality guidelines, particularly Q7 and Q10, the European GMP text and the PIC/S guides.

The question worth asking is not whether the supplier has a procedure for non-conforming material. It is: in the last case, what did you do with the material, and who signed the decision before it moved?

The credit note is not a disposition

A credit note closes a financial transaction. It does not close the material. The batch still exists, still has a test history, and still has to be assigned a fate: reworked, retested, downgraded, or destroyed. A file that contains the credit note and nothing else has recorded the money and lost the material.

The disposition record should name the batch, the quantity, the reason, the route chosen, the person who decided, and the date. Where the route is destruction, it should name the method and the witness. That last item is the one auditors ask about, because destruction is the only disposition that cannot be verified afterwards by inspecting the goods.

Quarantine, and the inventory nobody owns

Returned material usually arrives into a quarantine area and stays there longer than anyone intends. The risk is not that it will be released deliberately. It is that a system migration, a stock count or a change of warehouse staff will eventually lose track of why it is there, at which point it becomes available stock with a label that says hold.

A physical hold with an electronic status, reviewed on a defined interval, with an owner named against each item, prevents this. It is unglamorous and it is the difference between a quarantine and a shelf.

When the material has crossed a border

A return across a customs boundary is not a logistics reversal. The material re-enters as an import, may attract duty, may require a destruction certificate in the destination country rather than the origin country, and may not be legally importable at all if its status is uncertain.

In that situation the realistic options narrow: destroy in place with a witnessed record, or downgrade in place if a local use and a local specification exist. Returning it to the site of origin is often the most expensive and slowest route, which is why the quality agreement should say who decides when a cross-border return is not practical.

What to write into the agreement

Who decides the disposition, within what period, and what evidence closes it. Whether a third-party determination is available when the two parties disagree. Who bears the cost of destruction. And an explicit statement that material found non-conforming after shipment is not downgraded and re-sold to the same customer under a different description.

That last sentence is unpleasant to write and prevents the single most damaging outcome available in this business: a customer discovering that the material they rejected came back with a new label. The deviation classification determines what has to be disclosed, and the classification should be applied before the commercial conversation begins rather than after it concludes.

The investigation that has to come first

A disposition decided before the cause is known will be decided again, because the cause is still present. The sequence is fixed: contain the material, establish what failed and why, decide the disposition in light of the cause, then verify that the cause was removed.

Compressing the sequence is tempting when a customer is waiting. It is also the reason some sites replace the same failure three times. The customer's urgency is real and it is satisfied by a replacement; the site's problem is only satisfied by the investigation, and the two run in parallel rather than in sequence.

What closes the file

Three documents: the disposition record with its decision and signature, the investigation with its root cause, and the effectiveness check showing that the next batches behaved. A file with the first two and not the third is a file that describes an intention. The complaint and CAPA loop is the same structure seen from the customer's side.

Frequently asked questions

What are the three disposition routes?

Return, where the material goes back and is credited or replaced; replacement, where a new batch is supplied and the failing lot is dispositioned separately; and downgrade, where the material is re-labelled against a different specification for a different use. The first two are logistics. The third is a change of identity.

Why is downgrade the risky route?

Because it requires three things to be true at once: a specification the material genuinely meets, a market and a customer that permit that grade, and a record that shows the decision was made before the material moved rather than after a complaint. If any of the three is missing, the downgrade is a relabelling of a non-conformance.

Can a failing batch be sold for research use?

Only if a research-grade specification exists, the material meets it, and the customer's use is genuinely outside pharmaceutical application. Research use is not a synonym for unspecified. A research grade with no defined tests is a market segment, not a release decision.

Who pays for the return?

That is a commercial term, and it should be in the agreement before the first shipment. The technical point is separate: whoever pays, the return has to be documented with the quantity, the condition on arrival, and a decision about whether the material is reworked, retested or destroyed.

Does a replacement close the investigation?

No. The replacement closes the customer's supply problem. The investigation closes the site's process problem, and the two are independent. A site that replaces quickly and investigates slowly will replace again.

What if the material has already been used?

Then the question becomes a recall or a market action, which is the customer's regulatory decision and not the supplier's. The supplier's obligation is to provide the information the customer needs to make it: which batches, how much, when shipped, and what the deviation was.